News
PAHC
18.15
-0.44%
-0.08
Weekly Report: what happened at PAHC last week (0513-0517)?
Weekly Report · 1d ago
Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 05/14 13:15
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
NASDAQ · 05/13 13:40
Interpreting Phibro (PAHC) International Revenue Trends
NASDAQ · 05/13 12:46
PHIBRO ANIMAL HEALTH CORP <PAHC.O>: MORGAN STANLEY RAISES TARGET PRICE TO $19.00 FROM $13.00
Reuters · 05/13 12:28
Weekly Report: what happened at PAHC last week (0506-0510)?
Weekly Report · 05/13 10:54
Phibro Animal Health Is Maintained at Underweight by Barclays
Dow Jones · 05/10 19:24
Phibro Animal Health Price Target Raised to $13.00/Share From $10.00 by Barclays
Dow Jones · 05/10 19:24
Barclays Maintains Underweight on Phibro Animal Health, Raises Price Target to $13
Benzinga · 05/10 19:15
PHIBRO ANIMAL HEALTH CORP <PAHC.O>: BARCLAYS RAISES TARGET PRICE TO $13 FROM $10
Reuters · 05/10 10:21
Phibro Animal Health Corporation Quarterly Report for the Period Ended March 31, 2024
Press release · 05/09 17:26
Phibro (PAHC) Q3 Earnings and Revenues Beat, Gross Margin Down
NASDAQ · 05/09 14:18
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Phibro Animal Health (PAHC) and Amphastar Pharmaceuticals (AMPH)
TipRanks · 05/09 10:11
PAHC Stock Earnings: Phibro Animal Health Beats EPS, Beats Revenue for Q3 2024
Phibro Animal Health reported earnings per share of 31 cents for the third quarter of 2024. The company reported revenue of $263.20 million. This was 3.29% better than the analyst estimate of $254.82 million. Phibro animal health also reported results for the fourth quarter of 2015.
Investorplace · 05/09 01:54
Phibro (PAHC) Reports Q3 Earnings: What Key Metrics Have to Say
NASDAQ · 05/09 00:00
Phibro Animal Health Q3 2024 Adj EPS $0.31 Beats $0.29 Estimate, Sales $263.200M Beat $254.825M Estimate
Phibro Animal Health reported quarterly earnings of $0.31 per share. The company reported quarterly sales of $263.200 million. This is a 7.12 percent increase over sales of the same period last year. Phibro beat the analyst consensus estimate of $.29 per share by 6.9 percent.
Benzinga · 05/08 21:39
Phibro Animal Non-GAAP EPS of $0.31, revenue of $263.2M
Seeking Alpha · 05/08 20:57
*Phibro Animal Health Backs FY24 Sales $980M-$1B >PAHC
Dow Jones · 05/08 20:42
*Phibro Animal Health Adjusts FY24 View To EPS 17C-EPS 30C >PAHC
Dow Jones · 05/08 20:41
*Phibro Animal Health 3Q Sales $263.2M >PAHC
Dow Jones · 05/08 20:39
More
Webull provides a variety of real-time PAHC stock news. You can receive the latest news about Phibro Animal through multiple platforms. This information may help you make smarter investment decisions.
About PAHC
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.